- Report
- May 2025
United States
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- May 2025
Middle East
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- May 2025
Asia Pacific
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- April 2025
- 268 Pages
Global
From €4960EUR$5,450USD£4,213GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2024
- 172 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- May 2025
United Kingdom
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- May 2025
North America
From €1907EUR$2,095USD£1,620GBP
€3632EUR$3,990USD£3,084GBP
- Report
- April 2025
Europe
From €3632EUR$3,990USD£3,084GBP
The Blood Grouping Reagent market is a subset of the Blood Banking industry. It is composed of products used to identify the ABO and Rh blood group of a patient. These reagents are used to determine the compatibility of a patient's blood with a potential donor's blood, and are essential for successful transfusions. The market is composed of a variety of reagents, including monoclonal and polyclonal antibodies, lectins, and enzymes. These reagents are used in a variety of tests, such as agglutination, precipitation, and ELISA.
The Blood Grouping Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Immucor, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and DiaMed. Show Less Read more
